UPDATE : Wednesday, August 12, 2020
상단여백
AZ’s 3-in-1 inhaler for COPD to compete with GSK’s Trelegy
AstraZeneca’s winning of approval for Breztri Aerosphere (ingredient: budes...
by Kim Yun-mi  |  2020-07-27 15:09
라인
Genexine wins regulatory nod for Covid-19 vaccine trial
Genexine said that the Ministry of Food and Drug Safety has approved its tr...
by Lee Han-soo  |  2020-07-24 17:10
라인
'Eylea T&E therapy ideal in treating wAMD'
Wet age-related macular degeneration (wAMD), the top cause of blindness for...
by Lee Han-soo  |  2020-07-24 11:29
라인
Regulator OKs Keytruda for head and neck cancer therapy
MSD Korea said that it has won expanded indication for its cancer immunothe...
by Shim Hyun-tai  |  2020-07-23 17:57
라인
LegoChem names China’s WuXi AppTec as provider of non-clinical trial service
LegoChem Bioscience said that it has designated WuXi AppTec, a Chinese cont...
by Lee Han-soo  |  2020-07-23 15:21
라인
Local researchers find eco-friendly, low-cost drug synthesis method
Local researchers said they have successfully developed a new eco-friendly ...
by Song Soo-youn  |  2020-07-23 15:20
라인
Prosecutors raid GSK Korea’s vaccine division
Prosecutors have raided GSK Korea’s vaccine division, an industry source sa...
by Kim Yun-mi  |  2020-07-23 11:04
라인
Genexine scores FDA nod for trials of GX-I7 combination therapy
Genexine has received U.S. Food and Drug Administration’s approval to condu...
by Lee Han-soo  |  2020-07-22 17:43
라인
AZ selects SK Bioscience as global supplier of Covid-19 vaccine
AstraZeneca said that it has inked a deal with SK Bioscience, an SK Chemica...
by Lee Han-soo  |  2020-07-22 12:15
라인
GC sells off North America business to Grifols
GC said that it has sold off its Montreal-based GC Biotherapeutics’ plasma ...
by Lee Han-soo  |  2020-07-21 18:31
라인
Helixmith to start trials of VM202 for treating rare disorder
Helixmith said that it has kicked off its phase 1 and 2a clinical trial for...
by Lee Han-soo  |  2020-07-21 17:10
라인
Genexine, Y Biologics to co-develop Covid-19 treatment
Genexine said that it would develop an antibody-based Covid-19 treatment, j...
by Lee Han-soo  |  2020-07-21 15:52
라인
GC LabCell’s tech wins patent for delivering gene therapy to brain
GC Labcell said Tuesday that it obtained a domestic patent for a compositio...
by Shim Hyun-tai  |  2020-07-21 15:52
라인
'Severe atopic dermatitis drug too expensive for adolescents'
The drug regulator expanded approval for Dupixent (ingredient: dupilumab), ...
by Kim Eun-young  |  2020-07-21 14:20
라인
GC makes plasma Covid-19 therapy for clinical trials
GC Pharma has taken the first step to commercialize its new plasma treatmen...
by Shim Hyun-tai  |  2020-07-20 17:30
라인
Eutilex’s cancer therapy won Canadian patent
Eutilex, a biotechnology firm specializing in cancer immunotherapy, said Fr...
by Shim Hyun-tai  |  2020-07-17 17:52
라인
Hanmi’s fatty liver drug won FDA’s fast-track designation
Hanmi Pharmaceutical said Thursday that the U.S. Food and Drug Administrati...
by Shim Hyun-tai  |  2020-07-16 15:57
라인
‘Stage-3 unresectable lung cancer patient has every reason to use Imfinzi’
“Before Imfinzi arrived, all physicians could do for a state-3 unresectable...
by Kim Yun-mi  |  2020-07-16 14:37
라인
Menarini Korea deletes controversial YouTube ad
Menarini Korea’s online advertisement of an athlete’s foot treatment depict...
by Kim Chan-hyuk  |  2020-07-16 14:16
라인
Samsung Biologics to develop 5 more cancer therapies of ImmuneOncia
Samsung Biologics said Wednesday that it has signed a CDO (contract develop...
by Shim Hyun-tai  |  2020-07-15 18:33
여백
여백
여백
Back to Top